Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth a summary of our purchases during the quarter ended March 31, 2024, of equity securities that are registered by MPC pursuant to Section 12 of the Securities Exchange Act of 1934, as amended.


					Millions of Dollars
Period	Total Number of Shares Purchased	Average Price Paid per Share(a)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(b)(c)
01/01/2024-01/31/2024	5,734,014	$	154.25	5,734,014	$	5,899
02/01/2024-02/29/2024	2,510,801	169.69		2,510,801	5,473
03/01/2024-03/31/2024	4,682,743	178.42		4,682,743	4,638
Total	12,927,558	166.00		12,927,558

(a)Amounts in this column reflect the weighted average price paid for shares repurchased under our share repurchase authorizations. The weighted average price includes any commissions paid to brokers during the relevant period.

(b)On May 2, 2023, we announced that our board of directors had approved a $5.0 billion share repurchase authorization. On October 25, 2023, we announced that our board of directors had approved an additional $5.0 billion share repurchase authorization. On April 30, 2024, we announced that our board of directors had approved an additional $5.0 billion share repurchase authorization that is not included in the maximum remaining amount that may yet be purchased set forth in the table above. These share repurchase authorizations have no expiration date.

(c)The maximum dollar value remaining has been reduced by the payment of any commissions paid to brokers during the relevant period.

Table of Contents

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information